颌骨放射性骨坏死的危险因素及拔牙作用:全国性队列研究
该研究纳入23,527例以放疗为主要治疗的头颈癌患者,分析颌骨放射性骨坏死(ORNJ)的危险因素。ORNJ总发生率为3.93/100人年,颊癌风险最高,使用类固醇有保护作用;放疗前拔牙无额外风险,放疗后拔牙风险随时间逐渐增加,4至5年达峰。
要点
- ORNJ总发生率为3.93/100人年,颊癌患者风险最高。
- 使用类固醇对ORNJ有保护作用。
- 放疗前拔牙不增加ORNJ风险,放疗后拔牙风险随时间增加,4至5年达峰。
核心结论
- ORNJ需对头颈癌幸存者终身关注,研究支持放疗前拔牙的作用,应努力预防治疗后拔牙,尤其是治疗后前4年。
研究设计与样本
- 全国性队列研究,纳入23,527例以放疗为主要治疗的头颈癌患者,采用Cox比例风险模型分析危险因素。
主要发现
- ORNJ总发生率为3.93/100人年。
- 颊癌的ORNJ风险最高。
- 使用类固醇具有保护作用。
- 放疗前拔牙未带来额外风险。
- 放疗后拔牙与ORNJ风险随时间逐渐增加相关,4至5年达峰。
临床怎么用
- 头颈癌幸存者需终身关注ORNJ。
- 支持放疗前拔牙。
- 应努力预防治疗后拔牙,尤其是治疗后前4年。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to investigate the risk factors, especially the use of certain drugs and the dental procedures, for osteoradionecrosis of the jaw (ORNJ) in patients with head and neck cancer undergoing irradiation as their primary treatment. METHODS: The cohort was composed of 23,527 patients with head and neck cancer. Cox proportional hazard models were used for risk factors analysis. RESULTS: The overall incidence of ORNJ is 3.93 per 100 person-years. Buccal cancer carried the highest ORNJ risk. The use of steroids had a protective effect. Preradiotherapy extraction posed no excess risk, whereas postradiotherapy extraction was associated with gradually increased risk of ORNJ over time that peaked at 4 to 5 years. CONCLUSION: ORNJ warrants life-long attention for head and neck cancer survivors. The present study strongly confirms the role of preirradiation dental extractions. Meanwhile, efforts should be made to prevent posttreatment extractions, especially in the first posttreatment 4 years. © 2017 Wiley Periodicals, Inc. Head Neck 39: 1313-1321, 2017.
引用
- Wang TH, Liu CJ, Chao TF, et al. Risk factors for and the role of dental extractions in osteoradionecrosis of the jaws: A national-based cohort study. Head Neck. 2017. PMID: 28370713. doi:10.1002/hed.24761
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。